HIV Drugs Market Size

HIV Drugs Market size was valued at USD 36.72 billion in 2024 and is likely to cross USD 79.29 billion by 2037, expanding at more than 6.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of HIV drugs is estimated at USD 38.62 billion.

The growth of the HIV drugs market can be attributed to prevailing cases of acquired immune deficiency syndrome (AIDS). AIDS is caused by the transmission of a virus named human immunodeficiency virus (HIV). The data released by World Health Organisation states that in 2020, there were 1.5 million people who acquired HIV, and 680,000 people died from HIV-related causes. WHO also claims that in 2020 there were 37.7 million people who are living with AIDS. On the back of emerging cases of AIDS, the market is expected to grow during the forecast period. Furthermore, the governments are raising expenditure for the prevention and treatment of the disease. According to a report released by Joint United Nations Programme on HIV/AIDS (UNAIDS), the availability of international and domestic resources for the prevention and treatment of AIDS reached USD 21.5 million by the end of 2020. On account of the availability of a humongous budget for the treatment of AIDS, the market is projected to grow during the forecast period. Furthermore, the pro-active participation from all over the world to eliminate AIDS is remarkable. The World Health Organization promulgates 1^st December as World AIDS Day to spread awareness about the prevention and treatment of the disease. The HIV drugs market is estimated to witness significant growth during the forecast period on account of the rising awareness amongst the people.